Texte Alternatif

With this move, Marchesini Group is acquiring 70% of the shares in Dott. Bonapace and expanding its already extensive machine park with new technologies that handle special products such as suppositories and capsules.

Texte Alternatif“We have made a number of important acquisitions in recent years, but Dott. Bonapace is our first venture into the laboratory machinery market,” commented Marchesini Group CEO Pietro Cassani (picture). “Entering this new segment - as was the case for the high-level software segment - will allow us to further diversify our portfolio of mechanical companies and better manage the supply chain during this current period of recovery”.

Following the acquisition, Marchesini Group and Dott. Bonapace at CPhI Worldwide will attend together in Milan from 9 to 11 November. For the occasion, Marchesini Group will be exhibiting a BL-A418 CW Print&Check machine, a solution designed to meet the needs of pharmaceutical product tracking for anti-counterfeiting purposes.

All rights reserved except agreement written by Emballage Digest or mention of the magazine